Brief: Spectral Medical Announces Tigris Clinical Trial Update
25/07/2023 15:17
July 25 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL MEDICAL ANNOUNCES TIGRIS CLINICAL TRIAL UPDATE
* SPECTRAL MEDICAL INC - HAS ENROLLED A TOTAL OF 69 PATIENTS
FOR
COMPANY'S TIGRIS TRIAL
* SPECTRAL MEDICAL INC - REMAINS ON PACE TO ACHIEVE ITS
TARGET
TIMELINE OF 90 PATIENTS ENROLLED AROUND END OF 2023
Source text for Eikon: ID:nGNX28YZx5
Further company coverage: EDT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%